Lannett Co Inc (LCI) stock prices updated...
 

Lannett Co Inc stock price

Lannett Co Inc latest news:


  • 12/01/2017 05:08:03

    BRIEF-Lannett Reports FDA Acceptance Of 505(B)(2) NDA For Cocaine Hydrochloride Topical Solution

    Lannett Company Inc(LCI): * LANNETT ANNOUNCES FDA ACCEPTANCE OF 505 NEW DRUG APPLICATION FOR COCAINE HYDROCHLORIDE TOPICAL SOLUTION, A PROPRIETARY ANESTHETIC PRODUCT. * LANNETT COMPANY(LCI) - ‍FDA HAS ASSIGNED A PRESCRIPTION DRUG USER FEE ACT GOAL DATE OF JULY 21, 2018, TEN MONTHS FROM OFFICIAL NDA SUBMISSION DATE​ Source text for Eikon: Further company coverage:

  • 11/06/2017 13:49:52

    BRIEF-Deerfield Management LP reports 8.28% passive stake in Lannett Co as of Oct 25, 2017-SEC filing‍​

    Deerfield Management L.P: * Deerfield Management LP reports a 8.28 percent passive stake in Lannett Company Inc (LCI) as of October 25, 2017-SEC filing‍​ Source text : Further company coverage:

  • More trends:

    Laredo PetroleumLPI | Las Vegas Sands Corp.LVS | LaSalle Hotel PropertiesLHO | LaSalle Hotel PropertiesLHO^H | LaSalle Hotel PropertiesLHO^I | LATAM Airlines Group S.A.LFL | Latin American Discovery FundLDF | Lazard Global Total Return and Income FundLGI | Lazard Ltd.LAZ | Lazard World Dividend & Income FundLOR |